News|Articles|February 28, 2025
Achieving EU GMP Annex 1 compliance through an end-to-end approach to contamination control
Author(s)West Pharmaceutical Services
Related Content
Trending on Pharmaceutical Technology
1
What Novartis's $3.2 Billion Enzyme Licensing Deal Means for Formulation
2
AAPS PharmSci 360: CMC Strategies, Part 1
3
CPHI Milan Names 2026 Pharma Awards Finalists
4
AAPS PharmSci 360: Microstructure Intelligence in Predictive Drug Development, Part 1
5